10x Genomics (NASDAQ:TXG) Earns Sell (E+) Rating from Weiss Ratings
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by analysts at Weiss Ratings in a research report issued to clients and investors on Thursday,Weiss Ratings reports. Several other analysts also recently commented on TXG. JPMorgan Chase & Co. dropped their price objective on 10x Genomics from $14.00 to $12.00 […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by analysts at Weiss Ratings in a research report issued to clients and investors on Thursday,Weiss Ratings reports. Several other analysts also recently commented on TXG. JPMorgan Chase & Co. dropped their price objective on 10x Genomics from $14.00 to $12.00 […]
